Medicinal product name Tasigna
Pharmaceutical form Capsule, hard
Strength 150 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L01EA03 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N112: 4 × 28
(150 mg)
PVC/PVDC/Al blister    EU/1/07/422/006  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/07/422/006
Date of authorisation Dec 20, 2010
Marketing authorisation holder, country Novartis Europharm Limited, Ireland